DRUGS & AGING
Scope & Guideline
Connecting research and practice for better aging outcomes.
Introduction
Aims and Scopes
- Geriatric Pharmacotherapy:
Research dedicated to understanding the pharmacokinetics and pharmacodynamics of drugs in older adults, including how aging affects drug metabolism and response. - Polypharmacy and Deprescribing:
Focused studies on the prevalence and effects of polypharmacy in older adults, including strategies for deprescribing potentially inappropriate medications to improve patient outcomes. - Chronic Disease Management:
Investigations into the management of chronic conditions prevalent among older adults, such as diabetes, hypertension, and cardiovascular diseases, with an emphasis on tailored pharmacological interventions. - Adverse Drug Reactions and Drug Interactions:
Research aimed at identifying and mitigating adverse drug reactions and interactions, especially in the context of multimorbidity and polypharmacy. - Quality of Life and Patient-Centered Care:
Studies that explore the impact of pharmacotherapy on the quality of life, emphasizing patient perspectives and outcomes in the context of aging. - Innovative Therapeutics:
Research into newer therapeutic agents and treatment modalities, including biologics and targeted therapies, specifically for older populations.
Trending and Emerging
- Digital Health and Telemedicine:
An increasing number of studies are focusing on the role of digital tools and telemedicine in managing medications and health outcomes for older adults, highlighting the need for innovative approaches in a rapidly changing healthcare environment. - Patient-Reported Outcomes and Quality of Life:
There is a growing emphasis on incorporating patient-reported outcomes in research, reflecting a trend towards more holistic approaches to treatment that prioritize the patient's perspective on their health and medication. - Pharmacogenomics in Aging:
Emerging interest in pharmacogenomic studies to personalize medication regimens for older adults, aiming to optimize therapeutic efficacy while minimizing adverse effects. - Use of Cannabis and Cannabinoids:
Research on the use of medical cannabis and cannabinoids among older adults is gaining traction, particularly in relation to pain management and quality of life improvements. - Focus on Frailty and Comprehensive Geriatric Assessment:
An increasing number of studies are honing in on frailty as a critical factor in medication management, advocating for comprehensive geriatric assessments to tailor pharmacological treatments.
Declining or Waning
- Anticholinergic Burden Studies:
While still relevant, there has been a noticeable decrease in dedicated studies focusing solely on anticholinergic burden, suggesting a potential shift towards broader polypharmacy and deprescribing discussions. - Traditional Pain Management Approaches:
Research centered around traditional pain management strategies, particularly opioid use, has seen reduced focus, likely due to increasing scrutiny over opioid prescribing and a shift towards non-pharmacological management. - Longitudinal Studies of Aging and Medication Use:
Fewer long-term studies tracking medication use and outcomes in aging populations indicate a potential waning interest in longitudinal methodologies in favor of more immediate, intervention-focused research.
Similar Journals
BMC Geriatrics
Pioneering studies for a brighter future in geriatrics.BMC Geriatrics is a leading open-access journal dedicated to advancing the field of geriatrics and gerontology. Published by BMC, this esteemed journal has been at the forefront of research since its inception in 2001, providing a vital platform for sharing innovative studies and insights that address the complexities of aging. With an impressive Q1 ranking in the 2023 category of Geriatrics and Gerontology and a solid Scopus ranking at #40 out of 116, BMC Geriatrics showcases high-impact research that influences clinical practices and policy-making. As a fully open-access publication, it ensures that groundbreaking research is freely available to researchers, practitioners, and students alike, promoting the diffusion of knowledge across the global healthcare community. This journal is crucial for anyone interested in the latest developments in elderly care, health issues affecting aging populations, and innovative interventions designed to improve quality of life among older adults.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Fostering Collaboration in Geriatric Health InnovationsJOURNAL OF THE AMERICAN GERIATRICS SOCIETY, published by Wiley, stands as a leading resource in the field of geriatrics and gerontology. Established in 1953 and converging into a comprehensive academic platform through 2024, this esteemed journal is recognized for its high impact, holding a Q1 ranking in its category for 2023. It serves as a vital conduit for innovative research, clinical practices, and policy discussions aimed at improving the health and well-being of older adults. With a commitment to advancing geriatric medicine, the journal contributes significantly to the ongoing dialogue among researchers, healthcare professionals, and students dedicated to this rapidly evolving field. Although currently not offering open access options, the journal remains invaluable for those seeking to access pivotal studies and reviews that shape the future of geriatrics.
Journal of Frailty & Aging
Enhancing understanding of health in older adults.Journal of Frailty & Aging, published by SPRINGER BASEL AG, is a leading platform dedicated to advancing research in the fields of aging, geriatrics, and gerontology. With an ISSN of 2260-1341 and an E-ISSN of 2273-4309, this journal has established itself as a pivotal resource for scholars and practitioners aiming to explore the complexities of frailty and its impact on aging populations. As of 2023, it proudly holds a Q3 classification in Aging and Q2 classifications in both Geriatrics and Gerontology, as well as Physiology (medical), alongside a notable Q1 ranking in Medicine (miscellaneous). The journal's Scopus ranks further reflect its quality and relevance, with rankings as high as #22 in Aging within the Biochemistry, Genetics and Molecular Biology category. The Journal of Frailty & Aging invites contributions that illuminate contemporary challenges and innovations in the field, offering Open Access to enhance the dissemination of knowledge. By publishing rigorous research and impactful reviews, the journal strives to foster a deeper understanding of health and well-being in older adults, making it an essential resource for researchers, healthcare professionals, and students engaged in this vital area of study.
Aging Medicine
Pioneering Research in Gerontology and GeriatricsAging Medicine, published by Wiley, is a pivotal open-access journal that has been at the forefront of research dedicated to the aging population since its inception in 2018. With a focus on both geriatric care and gerontology, the journal serves as a crucial resource for researchers, healthcare professionals, and students interested in understanding the complexities of aging and the related medical challenges. Although it holds a Q3 quartile ranking in the fields of Aging and Geriatrics and Gerontology according to the 2023 metrics, the journal continues to effectively disseminate valuable research and insights, helping to bridge gaps in knowledge and practice. With an E-ISSN of 2475-0360, it offers an open-access model that ensures broader accessibility to its published content, thus promoting collaboration and innovation across disciplines. As the journal converges towards 2024, it remains committed to evolving with the dynamics of aging research, making it a significant platform for the exchange of ideas and advancements in this essential field.
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
Navigating the future of gerontology and geriatrics.ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, published by SPRINGER HEIDELBERG, is an authoritative journal dedicated to advancing the field of geriatrics and gerontology. With its ISSN 0948-6704 and E-ISSN 1435-1269, this journal has been a significant source of scholarly articles since its inception in 1995, catering to researchers and practitioners amid the growing importance of ageing studies. While it currently holds a Q4 ranking in Geriatrics and Gerontology and a Q3 ranking in Gerontology and Social Sciences, its contribution spans vital topics related to health ethics and legal aspects—reflecting a comprehensive view of the challenges faced in elder care. Although it is not an open-access journal, its rigorous peer-review process ensures that the research published is of high quality and relevance. Based in Heidelberg, Germany, the journal aims to foster discourse and disseminate crucial research findings that impact the health of elderly populations, making it an essential resource for researchers, healthcare professionals, and students devoted to improving geriatric care and understanding the complexities associated with ageing.
Journal of Pharmaceutical Health Care and Sciences
Enhancing global health through open access pharmaceutical knowledge.The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.
PHARMAZIE
Pioneering insights in toxicology and pharmaceutics.PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.
European Journal of Geriatrics and Gerontology
Advancing research in aging for a healthier tomorrow.Welcome to the European Journal of Geriatrics and Gerontology, a peer-reviewed platform dedicated to advancing knowledge and research in the fields of geriatrics and gerontology. Published by GALENOS PUBL HOUSE, this journal serves as a critical resource for researchers, healthcare professionals, and students who are involved in the care, treatment, and study of elderly populations. Since its inception in 2019 and running through 2024, the journal aims to foster interdisciplinary collaboration and disseminate innovative research that addresses the unique challenges faced by older adults. With an ISSN of 2687-2625, the journal is classified in the Q4 quartile of the Geriatrics and Gerontology category, signifying its emerging influence within the academic community, despite its current Scopus ranking of #113 out of 116, reflecting a rich opportunity for growth and visibility. Although the journal is not open access, it maintains a commitment to scholarly rigor and quality. Engage with the European Journal of Geriatrics and Gerontology to contribute to and learn from the evolving discourse in aging research.
Geriatrie et Psychologie Neuropsychiatrie du Vieillissement
Exploring Innovations in Geriatric Care and NeuropsychiatryGeriatrie et Psychologie Neuropsychiatrie du Vieillissement is a pivotal academic journal dedicated to the multidisciplinary study of aging, encompassing the fields of geriatrics, neuropsychiatry, and psychological health in the elderly population. Published by JOHN LIBBEY EUROTEXT LTD, this journal fosters knowledge dissemination and innovation, contributing to the understanding of the complexities faced by aging individuals. With a broad scope that includes biological psychiatry and neuropsychology, it serves as a vital resource for researchers, healthcare professionals, and students engaged in geriatric medicine and mental health. Although currently classified in the Q4 category across various relevant medical and psychological disciplines, the journal addresses critical topics that are essential for enhancing quality of care and improving patient outcomes. Additionally, the journal is accessible via open access options, promoting wide-ranging readership and collaboration within the academic community. As the field continuously evolves, Geriatrie et Psychologie Neuropsychiatrie du Vieillissement remains commited to pushing the boundaries of research and practice in gerontology and neuropsychiatry.
Aging Medicine and Healthcare
Pioneering Solutions for the Challenges of AgingAging Medicine and Healthcare is a leading Open Access journal dedicated to advancing the understanding of geriatric health and the complexities of aging. Published by the Asia Pacific League Clinical Gerontology & Geriatrics, this innovative journal began its journey in 2019 and has since established itself as an important resource for healthcare professionals, researchers, and students interested in the fields of geriatrics and gerontology. With an impact factor that reflects its growing significance (ranked in the 21st percentile within its category), the journal aims to disseminate high-quality research and practical insights that can inform clinical practice and enhance patient care for aging populations. As an Open Access publication, it ensures that research findings are freely accessible, fostering collaboration and knowledge sharing among academics and practitioners globally. The journal is poised to be a vital platform for innovative studies, systematic reviews, and case reports that illuminate the challenges and opportunities in aging medicine.